In a filing, Immunocore Holdings plc ADR revealed its HEAD OF R&D Berman David M unloaded Company’s shares for reported $2.18 million on Sep 30 ’25. In the deal valued at $35.23 per share,61,849 shares were sold. As a result of this transaction, Berman David M now holds 0 shares worth roughly $0.0.
Then, Berman David M sold 22,532 shares, generating $803,699 in total proceeds. Upon selling the shares at $35.67, the HEAD OF R&D now owns 0 shares.
Before that, Berman David M sold 200 shares. Immunocore Holdings plc ADR shares valued at $7,002 were divested by the HEAD OF R&D at a price of $35.01 per share. As a result of the transaction, Berman David M now holds 0 shares, worth roughly $0.0.
Deutsche Bank began covering IMCR with “Buy” recommendation on May 27, 2025. Morgan Stanley revised its rating on December 13, 2024. It rated IMCR as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of IMCR
On Friday, Immunocore Holdings plc ADR [NASDAQ:IMCR] saw its stock fall -4.03% to $32.4. Over the last five days, the stock has lost -5.29%. Immunocore Holdings plc ADR shares have risen nearly 5.99% since the year began. Nevertheless, the stocks have risen 9.83% over the past one year.
How much short interest is there in Immunocore Holdings plc ADR?
A steep rise in short interest was recorded in Immunocore Holdings plc ADR stocks on 2025-09-30, dropping by -0.37 million shares to a total of 8.36 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 8.73 million shares. There was a decline of -4.43%, which implies that there is a negative sentiment for the stock.
